Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabrice Andre

Showing results (51-60 of 141) with videos related to

Pageof 15
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 30, 2005
Mitotic index and benefit of adjuvant anthracycline-based chemotherapy in patients with early breast cancerFabrice Andre, Ahmed Khalil, Khemaies Slimane, et al.
BMC Cancer|October 27, 2015
Patterns of resource utilization and cost for postmenopausal women with hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer in EuropeGuy Jerusalem, Patrick Neven, Nina Marinsek, et al.
The Oncologist|April 28, 2010
Estrogen receptor expression and docetaxel efficacy in patients with metastatic breast cancer: a pooled analysis of four randomized trialsFabrice Andre, Kristine Broglio, Lajos Pusztai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 30, 2008
Estrogen receptor expression and efficacy of docetaxel-containing adjuvant chemotherapy in patients with node-positive breast cancer: results from a pooled analysisFabrice Andre, Kristine Broglio, Henri Roche, et al.
Breast Cancer Research : BCR|May 1, 2008
Evaluation of biological pathways involved in chemotherapy response in breast cancerAttila Tordai, Jing Wang, Fabrice Andre, et al.
Cancer|April 7, 2009
Fine-needle aspiration for nucleic acid-ased molecular analyses in breast cancerCatherine Uzan, Fabrice Andre, Veronique Scott, et al.
Breast Cancer Research and Treatment|December 22, 2009
Amplification of fibroblast growth factor receptor-1 in breast cancer and the effects of brivanib alaninateChristine Y Shiang, Yuan Qi, Bailiang Wang, et al.
BMC Bioinformatics|March 28, 2008
Prediction of the outcome of preoperative chemotherapy in breast cancer using DNA probes that provide information on both complete and incomplete responsesRené Natowicz, Roberto Incitti, Euler Guimarães Horta, et al.
Human Pathology|May 18, 2012
Tissue-based predictors of germ-line BRCA1 mutations: implications for triaging of genetic testingJeannine de la Cruz, Fabrice Andre, Robyn K Harrell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 27, 2010
Phase I study of everolimus plus weekly paclitaxel and trastuzumab in patients with metastatic breast cancer pretreated with trastuzumabFabrice Andre, Mario Campone, Ruth O'Regan, et al.
Pageof 15

Showing results (51-60 of 141) with videos related to

Sort By:
Pageof 15
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 30, 2005
Mitotic index and benefit of adjuvant anthracycline-based chemotherapy in patients with early breast cancerFabrice Andre, Ahmed Khalil, Khemaies Slimane, et al.
BMC Cancer|October 27, 2015
Patterns of resource utilization and cost for postmenopausal women with hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer in EuropeGuy Jerusalem, Patrick Neven, Nina Marinsek, et al.
The Oncologist|April 28, 2010
Estrogen receptor expression and docetaxel efficacy in patients with metastatic breast cancer: a pooled analysis of four randomized trialsFabrice Andre, Kristine Broglio, Lajos Pusztai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 30, 2008
Estrogen receptor expression and efficacy of docetaxel-containing adjuvant chemotherapy in patients with node-positive breast cancer: results from a pooled analysisFabrice Andre, Kristine Broglio, Henri Roche, et al.
Breast Cancer Research : BCR|May 1, 2008
Evaluation of biological pathways involved in chemotherapy response in breast cancerAttila Tordai, Jing Wang, Fabrice Andre, et al.
Cancer|April 7, 2009
Fine-needle aspiration for nucleic acid-ased molecular analyses in breast cancerCatherine Uzan, Fabrice Andre, Veronique Scott, et al.
Breast Cancer Research and Treatment|December 22, 2009
Amplification of fibroblast growth factor receptor-1 in breast cancer and the effects of brivanib alaninateChristine Y Shiang, Yuan Qi, Bailiang Wang, et al.
BMC Bioinformatics|March 28, 2008
Prediction of the outcome of preoperative chemotherapy in breast cancer using DNA probes that provide information on both complete and incomplete responsesRené Natowicz, Roberto Incitti, Euler Guimarães Horta, et al.
Human Pathology|May 18, 2012
Tissue-based predictors of germ-line BRCA1 mutations: implications for triaging of genetic testingJeannine de la Cruz, Fabrice Andre, Robyn K Harrell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 27, 2010
Phase I study of everolimus plus weekly paclitaxel and trastuzumab in patients with metastatic breast cancer pretreated with trastuzumabFabrice Andre, Mario Campone, Ruth O'Regan, et al.
Pageof 15